Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.030
+0.010 (0.98%)
Feb 3, 2026, 4:00 PM EST - Market closed
Evogene Market Cap
Evogene has a market cap or net worth of $8.79 million as of February 3, 2026. Its market cap has decreased by -13.73% in one year.
Market Cap
8.79M
Enterprise Value
11.65M
1-Year Change
-13.73%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $8.79M, a decrease of -68.61%. That is a compound annual growth rate of -6.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 8.87M | 7.95% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revelation Biosciences | 9.64M |
| Ernexa Therapeutics | 9.58M |
| Chemomab Therapeutics | 9.54M |
| Quince Therapeutics | 9.47M |
| Pulmatrix | 9.39M |
| CytoMed Therapeutics | 9.31M |
| Kiora Pharmaceuticals | 8.80M |
| BiomX | 8.73M |